BMP3 promoter methylation analysis in blood, stool, and tissue samples has shown sensitivity ranging from 33.3% to 56.66% and specificity from 85% to 94% for diagnosing CRC and advanced adenoma [19,21]. This evidence concerns the gene BMP3 and colorectal carcinoma.